The integration of generative artificial intelligence across healthcare delivery, payer operations, biopharmaceutical research and clinical trials represents one of the fastest-growing enterprise technology markets. Driven by clinical workforce burnout, rising administrative costs and the need to compress drug discovery timelines, spending on domain specific artificial intelligence software and infrastructure has accelerated rapidly.
Within this expanding landscape, Anthropi
Nelson Advisors
Aug 26
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.